📰 Mutation Testing News
Mutation Testing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mutation Testing. Real-time updates on events, politics, business and more.
March 28, 2024
— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients —
March 28, 2024
— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients — — If...
February 19, 2024
First EGFR inhibitor and targeted treatment to demonstrate progression-free survival benefit in Stage III setting ...
February 19, 2024
AstraZeneca's Tagrisso approved in the US for EGFRm non-small cell lung cancer with chemotherapy. FLAURA2 trial results show significant benefit.
January 5, 2024
Modern Java/JVM Build Practices. Contribute to binkley/modern-java-practices development by creating an account on GitHub.
October 16, 2023
WILMINGTON, Del.--(BUSINESS WIRE)--Oct 16, 2023--
September 11, 2023
Combination reduced the risk of disease progression by 38% versus TAGRISSO monotherapy, the current 1st-line global standard of care ...
May 17, 2023
* Results support potential for a new treatment option that builds on the benefit of first-line standard of care Tagrisso monotherapy Positive high-level results from the FLAURA2 Phase III trial... | May 17, 2023
May 17, 2023
Results support potential for a new treatment option that builds on the benefit of first-line standard of care TAGRISSO monotherapy ... | May 17, 2023